Insider Buy/Sell Details for the Biotechnology Industry — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (150)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,182
Price
$29.67
Total Value
$153.75K
Shares Held After
377,802
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.57
Total Value
$857.24K
Shares Held After
314,000
% of Holdings
31.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$28.13
Total Value
$334.21K
Shares Held After
377,802
% of Holdings
3.0%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
5,147
Price
$116.58
Total Value
$600.06K
Shares Held After
3,946
% of Holdings
56.6%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
2,086
Price
$115.73
Total Value
$241.41K
Shares Held After
9,093
% of Holdings
18.7%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
1,100
Price
$114.52
Total Value
$125.97K
Shares Held After
11,179
% of Holdings
9.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
8,744
Price
$116.55
Total Value
$1.02M
Shares Held After
9,938
% of Holdings
46.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
15,843
Price
$116.12
Total Value
$1.84M
Shares Held After
18,682
% of Holdings
45.9%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
4,744
Price
$116.54
Total Value
$552.87K
Shares Held After
5,683
% of Holdings
45.5%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
4,446
Price
$115.70
Total Value
$514.39K
Shares Held After
10,427
% of Holdings
29.9%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
3,506
Price
$34.11
Total Value
$119.59K
Shares Held After
257,075
% of Holdings
1.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
20,000
Price
$2.07
Total Value
$41.37K
Shares Held After
2,856,963
% of Holdings
0.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$574.23
Total Value
$22.97K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$572.44
Total Value
$45.79K
Shares Held After
324,483
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$570.70
Total Value
$68.48K
Shares Held After
324,563
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$569.90
Total Value
$136.78K
Shares Held After
324,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$566.58
Total Value
$45.33K
Shares Held After
324,923
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$563.88
Total Value
$45.11K
Shares Held After
325,003
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.35
Total Value
$22.49K
Shares Held After
325,083
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$560.66
Total Value
$67.28K
Shares Held After
325,123
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$558.60
Total Value
$67.03K
Shares Held After
325,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$557.43
Total Value
$133.78K
Shares Held After
325,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$555.60
Total Value
$44.45K
Shares Held After
325,603
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$554.30
Total Value
$44.34K
Shares Held After
325,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$552.86
Total Value
$88.46K
Shares Held After
325,763
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
725
Price
$551.82
Total Value
$400.07K
Shares Held After
325,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
432
Price
$550.99
Total Value
$238.03K
Shares Held After
326,648
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
757
Price
$549.59
Total Value
$416.04K
Shares Held After
327,080
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$548.87
Total Value
$661.94K
Shares Held After
327,837
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,171
Price
$547.99
Total Value
$641.70K
Shares Held After
329,043
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
309
Price
$546.75
Total Value
$168.94K
Shares Held After
330,214
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$544.90
Total Value
$697.47K
Shares Held After
330,523
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,032
Price
$544.17
Total Value
$561.59K
Shares Held After
331,803
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
408
Price
$542.87
Total Value
$221.49K
Shares Held After
332,835
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$542.06
Total Value
$379.44K
Shares Held After
333,243
% of Holdings
0.2%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$41.03
Total Value
$83.46K
Shares Held After
221,388
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
627
Price
$26.33
Total Value
$16.51K
Shares Held After
20,598
% of Holdings
3.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,786
Price
$23.19
Total Value
$134.15K
Shares Held After
9,110
% of Holdings
38.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$96.72
Total Value
$1.64M
Shares Held After
180,209
% of Holdings
8.6%
Greenland Mines Ltd (GRML)
El-Dada Riad Hussein — Former Director
Shares
3,500
Price
$9.35
Total Value
$32.73K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,800
Price
$28.56
Total Value
$165.65K
Shares Held After
377,802
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,081
Price
$27.57
Total Value
$167.65K
Shares Held After
383,602
% of Holdings
1.6%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
18,698
Price
$28.61
Total Value
$534.95K
Shares Held After
220,867
% of Holdings
7.8%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
8,094
Price
$27.52
Total Value
$222.75K
Shares Held After
239,565
% of Holdings
3.3%
Showing 1–50 of 150 transactions (page 1 of 3)